Selected Grants
SONATA-HCM A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of SOtaglifloziN in symptomATic obstructive And non-obstructive Hypertrophic CardioMyopathy (SONATA-HCM)
Clinical TrialCo Investigator · Awarded by Lexicon Pharmaceuticals · 2025 - 2027An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of EDG-7500 in Adults with Hypertrophic Cardiomyopathy
Clinical TrialCo Investigator · Awarded by Edgewise Therapeutics, Inc. · 2025 - 2027Mavacamten & Symptomatic nHCM
Clinical TrialCo Investigator · Awarded by MyoKardia, Inc. · 2023 - 2027MAPLE-HCM(CY6032)
Clinical TrialCo Investigator · Awarded by Cytokinetics, Inc. · 2023 - 2026External Relationships
- Bristol Myers Squibb
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.